These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29728507)

  • 21. T-cells behaving badly: structural insights into alloreactivity and autoimmunity.
    Ely LK; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2008 Oct; 20(5):575-80. PubMed ID: 18678247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling.
    Natarajan K; Jiang J; May NA; Mage MG; Boyd LF; McShan AC; Sgourakis NG; Bax A; Margulies DH
    Front Immunol; 2018; 9():1657. PubMed ID: 30065727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and Unbound States.
    Alba J; D'Abramo M
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models.
    Margulies DH
    Curr Opin Immunol; 1997 Jun; 9(3):390-5. PubMed ID: 9203420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM.
    Saotome K; Dudgeon D; Colotti K; Moore MJ; Jones J; Zhou Y; Rafique A; Yancopoulos GD; Murphy AJ; Lin JC; Olson WC; Franklin MC
    Nat Commun; 2023 Apr; 14(1):2401. PubMed ID: 37100770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricks with tetramers: how to get the most from multimeric peptide-MHC.
    Wooldridge L; Lissina A; Cole DK; van den Berg HA; Price DA; Sewell AK
    Immunology; 2009 Feb; 126(2):147-64. PubMed ID: 19125886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
    Gee MH; Sibener LV; Birnbaum ME; Jude KM; Yang X; Fernandes RA; Mendoza JL; Glassman CR; Garcia KC
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7369-E7378. PubMed ID: 30021852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational flexibility of a free and TCR-bound pMHC-I protein investigated by long-term molecular dynamics simulations.
    Tomasiak L; Karch R; Schreiner W
    BMC Immunol; 2022 Jul; 23(Suppl 1):36. PubMed ID: 35902791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell allorecognition: a case of mistaken identity or déjà vu?
    Archbold JK; Macdonald WA; Burrows SR; Rossjohn J; McCluskey J
    Trends Immunol; 2008 May; 29(5):220-6. PubMed ID: 18378495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated TCRs remain marked for internalization after dissociation from pMHC.
    Coombs D; Kalergis AM; Nathenson SG; Wofsy C; Goldstein B
    Nat Immunol; 2002 Oct; 3(10):926-31. PubMed ID: 12244312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease.
    Kedzierska K; Koutsakos M
    Viral Immunol; 2020 Apr; 33(3):160-178. PubMed ID: 32286182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural engineering of pMHC reagents for T cell vaccines and diagnostics.
    Mitaksov V; Truscott SM; Lybarger L; Connolly JM; Hansen TH; Fremont DH
    Chem Biol; 2007 Aug; 14(8):909-22. PubMed ID: 17719490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
    Lanzarotti E; Marcatili P; Nielsen M
    Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why must T cells be cross-reactive?
    Sewell AK
    Nat Rev Immunol; 2012 Sep; 12(9):669-77. PubMed ID: 22918468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cellular environment regulates in situ kinetics of T-cell receptor interaction with peptide major histocompatibility complex.
    Liu B; Chen W; Natarajan K; Li Z; Margulies DH; Zhu C
    Eur J Immunol; 2015 Jul; 45(7):2099-110. PubMed ID: 25944482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating Experiment and Theory to Understand TCR-pMHC Dynamics.
    Buckle AM; Borg NA
    Front Immunol; 2018; 9():2898. PubMed ID: 30581442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection.
    Buslepp J; Wang H; Biddison WE; Appella E; Collins EJ
    Immunity; 2003 Oct; 19(4):595-606. PubMed ID: 14563323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.
    Lorenz FKM; Ellinger C; Kieback E; Wilde S; Lietz M; Schendel DJ; Uckert W
    Hum Gene Ther; 2017 Dec; 28(12):1158-1168. PubMed ID: 28950731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.